Sequoia Pharmaceuticals Inc
Company Information
Gaithersburg, MD
United States
Phone: 1 240 632 0094
Fax: 1 240 632 0465
Overview
Sequoia Pharmaceuticals discovers and develops unique treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant disease. Most new anti-viral drugs were designed to block the most prevalent form of a pathogen, but these drugs become less potent due to the emergence of drug-resistant mutations. Sequoia's mission is to discover and develop new antivirals which are active against the most prevalent form of the virus but also anticipates the emergence of drug resistance forms thereby maintaining potency over time.
Corporate Structure
CHIEF EXECUTIVE OFFICER
TOP EXECUTIVES
Daniel L. Kisner Board of Directors
Greg Zakarian Cfo
Julie Eskay-Eagle Director
Michael Eissenstat
Gary G Altman
John W Erickson Founder
Denis Lucquin Managing Partner
Sergei V Gulnik Vice President, Biochemistry
Wayne T. Hockmeyer Board of Directors
Douglas Ludtke
Brian Wynne Vice President of Clinical Development and Medical Affairs
Christopher Mirabelli Managing Director
Robert Guttendorf
Elena Afonina
Edward M. Connor Board of Directors
Dean Kisner Chairman
Doug Onsi Board of Directors
Linda Peters Senior Vice President, Regulatory Affairs
